Analytical characterization of coformulated antibodies as combination therapy

When two therapeutic agents are combined in a single formulation, i.e., coformulated, the quality and safety of the individual agents must be preserved. Here we describe an approach to evaluate the quality attributes of two individual monoclonal antibodies (mAbs), designated mAb-A and mAb-B, in cofo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jun, Kim, Yoen Joo, Cao, Mingyan, De Mel, Niluka, Miller, Kenneth, Bee, Jared S., Wang, Jihong, Wang, Xiangyang, Albarghouthi, Methal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153825/
https://www.ncbi.nlm.nih.gov/pubmed/32138591
http://dx.doi.org/10.1080/19420862.2020.1738691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153825/
https://www.ncbi.nlm.nih.gov/pubmed/32138591
http://dx.doi.org/10.1080/19420862.2020.1738691

Ejemplares similares